Decrease in susceptibility toward induction of apoptosis and alteration inG(1) checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine)

Citation
K. Sugiyama et al., Decrease in susceptibility toward induction of apoptosis and alteration inG(1) checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-hydroxystaurosporine), CANCER RES, 59(17), 1999, pp. 4406-4412
Citations number
37
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
59
Issue
17
Year of publication
1999
Pages
4406 - 4412
Database
ISI
SICI code
0008-5472(19990901)59:17<4406:DISTIO>2.0.ZU;2-7
Abstract
7-Hydroxystaurosporine (UCN-01) is a protein kinase inhibitor that is under development as an anticancer agent in the United States and Japan. Long-te rm exposure of human A549 non-small cell lung cancer cells to UCN-01 furnis hed cells (A549/UCN) with acquired resistance against UCN-01. In this study , the sensitivity of these cells toward the growth-arresting properties of certain conventional cytotoxic agents was explored. Cells were not cross-re sistant against adriamycin, Taxol, staurosporine, and UCN-02, but they disp layed 14- and 4.4-fold resistance against cisplatin and mitomycin C, respec tively. Previous studies on the mechanism(s) of action of UCN-01 suggest th at induction of apoptosis and G(1) phase accumulation are important for its anticancer activity; therefore, we compared induction of apoptosis and cel l cycle distribution caused by UCN-01 in wild-type A549 and A549/UCN cells using flow cytometry. UCN-01 (0.4 mu M) induced apoptosis (62% terminal deo xynucleotidyl transferase mediated nick end labeling-positive cells) in A54 9 cells, but not in A549/UCN cells. The percentages of cells that accumulat ed in G(1) when exposed to UCN-01 (0.4 mu M) were 22% in A549 cells and 67% in A549/UCN cells. These results suggest that acquired resistance of cance r cells against UCN-01 is characterized by attenuation of apoptosis inducti on associated with reinforcement of the G(1) checkpoint and that apoptosis regulation is drastically altered in A549/UCN cells as compared with A549 c ells. Cyclin-dependent kinase (CDK) inhibitor proteins p21 and p27 in A549/ UCN cells were up-regulated, which was accompanied by overexpression of G(1 ) cyclins D1 and E, but UCN-01 hardly affected levels of these proteins. In contrast, cyclin A, cyclin B1, retinoblastoma, and CDK2 proteins were appa rently down-regulated, without changes in CDK4/6, UCN-01 hardly affected th e expression level of cyclin B1 and induced dephosphorylation of retinoblas toma in both cell types. UCN-01 induced down-regulation of cyclin A level a nd CDK2 activity accompanied with its dephosphorylation in A549/UCN cells, but not in A549 cells. The antiapoptotic protein bcl-2 was apparently up-re gulated in A549/UCN cells, however, bcl-xL, another antiapoptotic protein, was down-regulated, without changes in bak and bar. Taken together, these r esults are consistent with the notion that induction of apoptosis and block of cell cycle in G(1) are important determinants of the sensitivity of can cer cells to UCN-01 and suggest that inhibition of CDK2 activity accompanie d by its dephosphorylation and decrease of expression level of cyclin A mig ht play an important role in the G(1) phase accumulation induced by UCN-01.